OM
Opaleye Management’s Fulcrum Therapeutics FULC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-285,000
| Closed | -$1.77M | – | 48 |
|
2024
Q2 | $1.77M | Buy |
285,000
+155,000
| +119% | +$961K | 0.4% | 43 |
|
2024
Q1 | $1.23M | Hold |
130,000
| – | – | 0.27% | 45 |
|
2023
Q4 | $878K | Buy |
+130,000
| New | +$878K | 0.23% | 44 |
|
2023
Q3 | – | Sell |
-143,600
| Closed | -$474K | – | 46 |
|
2023
Q2 | $474K | Buy |
+143,600
| New | +$474K | 0.11% | 46 |
|
2022
Q2 | – | Sell |
-136,000
| Closed | -$3.22M | – | 49 |
|
2022
Q1 | $3.22M | Buy |
+136,000
| New | +$3.22M | 1% | 28 |
|
2021
Q1 | – | Sell |
-88,300
| Closed | -$1.03M | – | 61 |
|
2020
Q4 | $1.03M | Sell |
88,300
-363,700
| -80% | -$4.26M | 0.14% | 53 |
|
2020
Q3 | $3.58M | Buy |
+452,000
| New | +$3.58M | 0.7% | 37 |
|